Author Question: Which of the following best defines payback period? A) It is the number of time periods before ... (Read 59 times)

hubes95

  • Hero Member
  • *****
  • Posts: 561
Which of the following best defines payback period?
 
  A) It is the number of time periods before the cash inflows of a proposed project exceed the amount of the initial investment.
  B) It is the number of time periods before the amount of the initial investment exceeds the cash inflows of a proposed project.
  C) It is the number of time periods before the cash inflows of a proposed project equal the amount of the initial investment.
  D) It is the number of time periods before the net expenditure exceeds the amount of the initial investment.

Question 2

For a normal distribution, as  changes, ________.
 
  A) the density of the function increases
  B) the median remains unchanged
  C) the distribution becomes wider
  D) the location of the distribution on the x-axis changes


jaaaaaaa

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

C

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library